These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 28446208)

  • 1. Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis.
    Andrés Cerezo L; Šumová B; Prajzlerová K; Veigl D; Damgaard D; Nielsen CH; Pavelka K; Vencovský J; Šenolt L
    Arthritis Res Ther; 2017 Apr; 19(1):79. PubMed ID: 28446208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils.
    Navrátilová A; Bečvář V; Baloun J; Damgaard D; Nielsen CH; Veigl D; Pavelka K; Vencovský J; Šenolt L; Andrés Cerezo L
    Sci Rep; 2021 Mar; 11(1):6063. PubMed ID: 33727634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and synovial fluid concentrations of cold-inducible RNA-binding protein in patients with rheumatoid arthritis.
    Yoo IS; Lee SY; Park CK; Lee JC; Kim Y; Yoo SJ; Shim SC; Choi YS; Lee Y; Kang SW
    Int J Rheum Dis; 2018 Jan; 21(1):148-154. PubMed ID: 27315340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis: Attenuated the production of inflammatory cytokines.
    Xia L; Shen H; Lu J
    Cytokine; 2015 Dec; 76(2):553-557. PubMed ID: 26159110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
    Damgaard D; Senolt L; Nielsen CH
    Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Increment of Synovial Soluble TYRO3 Correlates with Disease Severity and Joint Inflammation in Patients with Rheumatoid Arthritis.
    Vullings J; Vago JP; Waterborg CEJ; Thurlings RM; Koenders MI; van Lent PLEM; van der Kraan PM; Amaral FA; van de Loo FAJ
    J Immunol Res; 2020; 2020():9690832. PubMed ID: 32964059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis.
    Šenolt L; Prajzlerová K; Hulejová H; Šumová B; Filková M; Veigl D; Pavelka K; Vencovský J
    Cytokine; 2017 Sep; 97():187-192. PubMed ID: 28662439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.
    Navrátilová A; Andrés Cerezo L; Hulejová H; Bečvář V; Tomčík M; Komarc M; Veigl D; Tegzová D; Závada J; Olejárová M; Pavelka K; Vencovský J; Šenolt L
    Front Immunol; 2021; 12():745523. PubMed ID: 34745117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-Resistant Pathways Are Associated With Disease Activity in Rheumatoid Arthritis and Are Subject to Disease Modification Through Metabolic Reprogramming: A Potential Novel Therapeutic Approach.
    Gallagher L; Cregan S; Biniecka M; Cunningham C; Veale DJ; Kane DJ; Fearon U; Mullan RH
    Arthritis Rheumatol; 2020 Jun; 72(6):896-902. PubMed ID: 31840936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome].
    Liu DF; Yan J; Guo MY; Wang C; Hu YH; Yang M; Yun MD; Luo Y; Zhang J; Li H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):272-5. PubMed ID: 24758074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Levels of Soluble ST2 were Associated with Rheumatoid Arthritis Disease Activity and Ameliorated Inflammation in Synovial Fibroblasts.
    Shi LJ; Liu C; Li JH; Zhu XY; Li YN; Li JT
    Chin Med J (Engl); 2018 Feb; 131(3):316-322. PubMed ID: 29363647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of P53 in peripheral blood and synovial mononuclear cells of rheumatoid arthritis and osteoarthritis patients and its relation to the degree of disease activity.
    Abou-Shousha SA; Salah E; Wagdy E
    Egypt J Immunol; 2005; 12(2):61-70. PubMed ID: 17977211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.
    Andrés Cerezo L; Kuklová M; Hulejová H; Vernerová Z; Pešáková V; Pecha O; Veigl D; Haluzík M; Pavelka K; Vencovský J; Senolt L
    Cytokine; 2013 Oct; 64(1):441-7. PubMed ID: 23714112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis.
    Penatti A; Facciotti F; De Matteis R; Larghi P; Paroni M; Murgo A; De Lucia O; Pagani M; Pierannunzii L; Truzzi M; Ioan-Facsinay A; Abrignani S; Geginat J; Meroni PL
    Arthritis Res Ther; 2017 May; 19(1):103. PubMed ID: 28526072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
    Talabot-Ayer D; McKee T; Gindre P; Bas S; Baeten DL; Gabay C; Palmer G
    Joint Bone Spine; 2012 Jan; 79(1):32-7. PubMed ID: 21441054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
    Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 patterns in synovium, serum and synovial fluid from treatment-naïve, early rheumatoid arthritis patients.
    Roşu A; Mărgăritescu C; Stepan A; Muşetescu A; Ene M
    Rom J Morphol Embryol; 2012; 53(1):73-80. PubMed ID: 22395503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.